ADVENZYMES

ADVANCED ENZYME TECHNOLOGIES

Small Cap BSE: 540025 NSE: ADVENZYMES
₹263.95
-0.8 (-0.3%)
  • Advice
  • Hold
As on 14 August, 2022 | 17:29

Advanced Enzyme Technologies Share Price

Advanced Enzyme Technologies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Advanced Enzyme Technologies Share Returns

  • Over 1 Month -4.17%
  • Over 3 Month -4.07%
  • Over 6 Month -15.39%
  • Over 1 Year -32.32%

Advanced Enzyme Technologies Key Statistics

P/E Ratio 29.5
PEG Ratio -0.9
Market Cap Cr 2,951
Price to Book Ratio 2.6
EPS 4.8
Dividend 0.7
Relative Strength Index 35.28
Money Flow Index 31.88
MACD Signal 1.12
Average True Range 9.22

Advanced Enzyme Technologies Investment Rating

  • Master Rating:
  • Advanced Enzyme Techs. has an operating revenue of Rs. 513.49 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 32% is great, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 16 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 53 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Advanced Enzyme Technologies Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 72
  • 71
  • 64
  • 65
  • 73
  • 71
  • Operating Expenses Qtr Cr
  • 61
  • 55
  • 51
  • 47
  • 46
  • 49
  • Operating Profit Qtr Cr
  • 11
  • 15
  • 13
  • 18
  • 26
  • 22
  • Depreciation Qtr Cr
  • 2
  • 3
  • 2
  • 2
  • 2
  • 2
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 2
  • 4
  • 3
  • 4
  • 7
  • 7
  • Net Profit Qtr Cr
  • 8
  • 14
  • 9
  • 13
  • 19
  • 15

Advanced Enzyme Technologies Technicals

EMA & SMA

Current Price
263.95
-0.8 (-0.3%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 280.41
  • 50 Day
  • 282.11
  • 100 Day
  • 289.46
  • 200 Day
  • 307.84
  • 20 Day
  • 284.62
  • 50 Day
  • 280.57
  • 100 Day
  • 286.8
  • 200 Day
  • 307.71

Advanced Enzyme Technologies Resistance and Support

PIVOT
₹266.86
Resistance
  • First Resistance
  • 269.86
  • Second Resistance
  • 274.95
  • Third Resistance
  • 277.95
Support
  • First Resistance
  • 261.75
  • Second Resistance
  • 258.75
  • Third Resistance
  • 253.65
  • RSI
  • 35.28
  • MFI
  • 31.88
  • MACD Single Line
  • 1.13
  • MACD
  • -1.99

Advanced Enzyme Technologies Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 96,084
  • 5,788,100
  • 60.24
  • Week
  • 133,202
  • 7,830,946
  • 58.79
  • 1 Month
  • 114,526
  • 4,258,077
  • 37.18
  • 6 Month
  • 187,463
  • 7,562,277
  • 40.34

Advanced Enzyme Technologies Result Highlights

Advanced Enzyme Technologies Synopsis

NSE-Chemicals-Specialty

Advanced Enzyme Tech is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 272.80 Cr. and Equity Capital is Rs. 22.36 Cr. for the Year ended 31/03/2022. Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018.
  • Market Cap
  • 2,951
  • Sales
  • 272
  • Shares in Float
  • 5.26
  • No of funds
  • 66
  • Yield
  • 0.38
  • Book Value
  • 6.14
  • U/D Vol ratio
  • 1.7
  • LTDebt / Equity
  • Alpha
  • -0.16
  • Beta
  • 0.89

Advanced Enzyme Technologies

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 52.7%
  • 52.7%
  • 52.71%
  • Mutual Funds
  • 6.05%
  • 6.46%
  • 8.5%
  • Foreign Portfolio Investors
  • 18.72%
  • 18.01%
  • 16.39%
  • Financial Institutions/ Banks
  • Individual Investors
  • 15.14%
  • 15.21%
  • 14.87%
  • Others
  • 7.39%
  • 7.62%
  • 7.53%

Advanced Enzyme Technologies Management

  • Name
  • Designation
  • Mr. Vasant Rathi
  • Non Executive Chairman
  • Mr. Mukund M Kabra
  • Whole Time Director
  • Ms. Rasika Rathi
  • Non Executive Director
  • Dr. Sunny Sharma
  • Non Executive Director
  • Mr. Rajesh Sharma
  • Independent Director
  • Mr. Kedar Jagdish Desai
  • Independent Director
  • Mr. Pramod Kasat
  • Independent Director
  • Mr. Nitin Desmukh
  • Independent Director
  • Mr. Vinodkumar Jajoo
  • Independent Director
  • Ms. Rajshree Patel
  • Independent Director

Advanced Enzyme Technologies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Advanced Enzyme Technologies Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-06
  • Quarterly Results
  • 2022-05-20
  • Audited Results & Final Dividend
  • 2022-02-05
  • Quarterly Results
  • 2021-11-02
  • Quarterly Results
  • 2021-08-07
  • Quarterly Results
  • Date
  • Purpose
  • Remarks
  • 2022-08-12
  • FINAL
  • Rs.1.00 per share(50%)Final Dividend
  • 2021-09-01
  • FINAL
  • Rs.0.90 per share(45%)Final Dividend

Advanced Enzyme Technologies MF Shareholding

  • Name
  • Amount(cr)
  • ICICI Prudential Equity & Debt Fund Growth
  • 19614
  • HDFC Small Cap Fund Growth
  • 12934
  • HDFC Multi Cap Fund Regular Growth
  • 5241
  • UTI Small Cap Fund Regular Growth
  • 2177
  • ICICI Prudential ESG Fund Regular Growth
  • 1412

Advanced Enzyme Technologies FAQs

What is Share Price of Advanced Enzyme Technologies ?

Advanced Enzyme Technologies share price is ₹263 As on 14 August, 2022 | 17:15

What is the Market Cap of Advanced Enzyme Technologies ?

The Market Cap of Advanced Enzyme Technologies is ₹2951.4 Cr As on 14 August, 2022 | 17:15

What is the P/E ratio of Advanced Enzyme Technologies ?

The P/E ratio of Advanced Enzyme Technologies is 29.5 As on 14 August, 2022 | 17:15

What is the PB ratio of Advanced Enzyme Technologies ?

The PB ratio of Advanced Enzyme Technologies is 2.6 As on 14 August, 2022 | 17:15

Q1FY23